Deregulated lipid sensing by intestinal CD36 in diet-induced hyperinsulinemic obese mouse model

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Buttet, Marjorie ^a   Poirier, Helene ^a   Traynard, Veronique ^b   Gaire, Kevin ^c   Tran, Thi Thu Trang ^c   Sundaresan, Sinju ^a   Besnard, Philippe ^a   Abumrad, Nada A ^a   Niot, Isabelle ^a  

^a Institut Médical de Génétique et d Immunologie   (France)

^b UNIVERSITY OF MICHIGAN   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CD36 ANTIGEN; CHYLOMICRON; LIPOPROTEIN; MESSENGER RNA; PALM OIL; STREPTOZOCIN; TRIACYLGLYCEROL; TRIGLYCERIDE RICH LIPOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOC2 GENE; ARTICLE; CACO 2 CELL LINE; CHEMICAL PHENOMENA; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GENE; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; IN VITRO STUDY; INSULIN TREATMENT; L FABP GENE; LIPID ABSORPTION; LIPID DIET; LIPID SENSING; MALE; METABOLIC SYNDROME X; MOUSE; MOUSE MODEL; MTP GENE; NONHUMAN; OBESITY; PLASMA CLEARANCE; POPULATION SIZE; PROCESS OPTIMIZATION; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; UPREGULATION; ANIMAL; DISEASE MODEL; HYPERINSULINISM; INTESTINE; LIPID METABOLISM; METABOLISM;

ANIMALS; ANTIGENS, CD36; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HYPERINSULINISM; INTESTINES; LIPID METABOLISM; MICE; OBESITY;

EID: 84953790940     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145626     Document Type: Article

References (52)

1. Freire RD, Cardoso MA, Gimeno SG, Ferreira SR. Dietary fat is associated with metabolic syndrome in Japanese Brazilians. Diabetes Care. 2005 Jul; 28(7):1779-85.
2. Zhu S, St-Onge MP, Heshka S, Heymsfield SB. Lifestyle behaviors associated with lower risk of having the metabolic syndrome. Metabolism. 2004 Nov; 53(11):1503-11.
3. Jackson KG, Walden CM, Murray P, Smith AM, Minihane AM, Lovegrove JA, et al. Greater impairment of postprandial triacylglycerol than glucose response in metabolic syndrome subjects with fasting hyperglycaemia. Metabolism. 2013 Aug; 62(8):1065-9. doi: 10.1016/j.metabol.2013.03.001
4. Kolovou GD, Anagnostopoulou KK, Pavlidis AN, Salpea KD, Iraklianou SA, Hoursalas IS, et al. Metabolic syndrome and gender differences in postprandial lipaemia. Eur J Cardiovasc Prev Rehabil. 2006 Aug; 13(4):661-4.
5. Shojaee-Moradie F, Ma Y, Lou S, Hovorka R, Umpleby AM. Prandial hypertriglyceridemia in metabolic syndrome is due to an overproduction of both chylomicron and VLDL triacylglycerol. Diabetes. 2013 Dec; 62(12):4063-9. doi: 10.2337/db13-0935
6. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007 Jul 18; 298(3):309-16.
7. Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG. Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA. 2008 Nov 12; 300(18):2142-52. doi: 10.1001/jama. 2008.621
8. Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014 Aug 16; 384 (9943):626-35. doi: 10.1016/S0140-6736(14)61177-6
9. Drover VA, Ajmal M, Nassir F, Davidson NO, Nauli AM, Sahoo D, et al. CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. J Clin Invest. 2005 May; 115(5):1290-7.
10. Masuda D, Hirano K, Oku H, Sandoval JC, Kawase R, Yuasa-Kawase M, et al. Chylomicron remnants are increased in the postprandial state in CD36 deficiency. J Lipid Res. 2009 May; 50(5):999-1011. doi: 10.1194/jlr.P700032-JLR200
11. Hsieh J, Longuet C, Maida A, Bahrami J, Xu E, Baker CL, et al. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. Gastroenterology. 2009 Sep; 137 (3):997-1005, e1-4. doi: 10.1053/j.gastro.2009.05.051
12. Nauli AM, Nassir F, Zheng S, Yang Q, Lo CM, Vonlehmden SB, et al. CD36 Is Important for Chylomicron Formation and Secretion and May Mediate Cholesterol Uptake in the Proximal Intestine. Gastroenterology. 2006 Oct; 131(4):1197-207.
13. Tran TT, Poirier H, Clement L, Nassir F, Pelsers MM, Petit V, et al. Luminal lipid regulates CD36 levels and downstream signaling to stimulate chylomicron synthesis. J Biol Chem. 2011 Jul 15; 286 (28):25201-10. doi: 10.1074/jbc.M111.233551
14. Siddiqi S, Saleem U, Abumrad NA, Davidson NO, Storch J, Siddiqi SA, et al. A novel multiprotein complex is required to generate the prechylomicron transport vesicle from intestinal ER. J Lipid Res. 2010 Jul; 51(7):1918-28. doi: 10.1194/jlr.M005611
15. Kuwasako T, Hirano K, Sakai N, Ishigami M, Hiraoka H, Yakub MJ, et al. Lipoprotein abnormalities in human genetic CD36 deficiency associated with insulin resistance and abnormal fatty acid metabolism. Diabetes Care. 2003 May; 26(5):1647-8
16. Farook VS, Puppala S, Schneider J, Fowler SP, Chittoor G, Dyer TD, et al. Metabolic syndrome is linked to chromosome 7q21 and associated with genetic variants in CD36 and GNAT3 in Mexican Americans. Obesity (Silver Spring). 2012 Oct; 20(10):2083-92
17. Geloen A, Helin L, Geeraert B, Malaud E, Holvoet P, Marguerie G. CD36 inhibitors reduce postprandial hypertriglyceridemia and protect against diabetic dyslipidemia and atherosclerosis. PLoS One. 2012; 7 (5):e37633. doi: 10.1371/journal.pone.0037633
18. Noel SE, Lai CQ, Mattei J, Parnell LD, Ordovas JM, Tucker KL. Variants of the CD36 gene and metabolic syndrome in Boston Puerto Rican adults. Atherosclerosis. 2010 Jul; 211(1):210-5. doi: 10.1016/j. atherosclerosis.2010.02.009
19. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, Pearce SF, et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem. 1999 Jul 2; 274 (27):19055-62.
20. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May; 226(1):497-509.
21. Sundaresan S, Shahid R, Riehl TE, Chandra R, Nassir F, Stenson WF, et al. CD36-dependent signaling mediates fatty acid-induced gut release of secretin and cholecystokinin. FASEB J. 2013 Mar; 27 (3):1191-202. doi: 10.1096/fj.12-217703
22. Tran TTT, Poirier H, Clement L, Nassir F, Pelsers MMAL, Petit V, et al. Luminal Lipid Regulates CD36 Levels and Downstream Signaling to Stimulate Chylomicron Synthesis. The Journal of Biological Chemistry. [doi: 10.1074/jbc.M111.233551]. 2011; 286(28):25201-10.
23. Poirier H, Degrace P, Niot I, Bernard A, Besnard P. Localization and regulation of the putative membrane fatty-Acid transporter (FAT) in the small intestine. Comparison with fatty acid-binding proteins (FABP). Eur J Biochem. 1996 Jun 1; 238(2):368-73.
24. Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes. 2011 Apr; 18(2):139-43. doi: 10.1097/MED.0b013e3283444b09
25. Martins IJ, Mortimer BC, Miller J, Redgrave TG. Effects of particle size and number on the plasma clearance of chylomicrons and remnants. J Lipid Res. 1996 Dec; 37(12):2696-705.
26. Jia L, Ma Y, Rong S, Betters JL, Xie P, Chung S, et al. Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis. J Lipid Res. 2010 Nov; 51(11):3135-44. doi: 10.1194/jlr.M006353
27. de Wit N, Derrien M, Bosch-Vermeulen H, Oosterink E, Keshtkar S, Duval C, et al. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. Am J Physiol Gastrointest Liver Physiol. 2012 Sep 1; 303(5):G589-99. doi: 10.1152/ajpgi.00488.2011
28. Poirier H, Niot I, Degrace P, Monnot MC, Bernard A, Besnard P. Fatty acid regulation of fatty acid-binding protein expression in the small intestine. Am J Physiol. 1997 Aug; 273(2 Pt 1):G289-95.
29. van der Veen JN, Kruit JK, Havinga R, Baller JF, Chimini G, Lestavel S, et al. Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. J Lipid Res. 2005 Mar; 46(3):526-34.
30. Smith J, Su X, El-Maghrabi R, Stahl PD, Abumrad NA. Opposite regulation of CD36 ubiquitination by fatty acids and insulin: effects on fatty acid uptake. J Biol Chem. 2008 May 16; 283(20):13578-85. doi: 10.1074/jbc.M800008200
31. de Wit NJ, Boekschoten MV, Bachmair EM, Hooiveld GJ, de Groot PJ, Rubio-Aliaga I, et al. Dosedependent effects of dietary fat on development of obesity in relation to intestinal differential gene expression in C57BL/6J mice. PLoS One. 2011; 6(4):e19145. doi: 10.1371/journal.pone.0019145
32. Riccardi G, Giacco R, Rivellese AA. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr. 2004 Aug; 23(4):447-56.
33. Abumrad NA, Davidson NO. Role of the gut in lipid homeostasis. Physiol Rev. 2012 Jul; 92(3):1061-85. doi: 10.1152/physrev.00019.2011
34. Peterson J, Bihain BE, Bengtsson-Olivecrona G, Deckelbaum RJ, Carpentier YA, Olivecrona T. Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport. Proc Natl Acad Sci U S A. 1990 Feb; 87(3):909-13.
35. Jong MC, Hofker MH, Havekes LM. Role of ApoCs in lipoprotein metabolism-Functional differences between ApoC1, ApoC2, and ApoC3. Arteriosclerosis Thrombosis and Vascular Biology. 1999 Mar; 19 (3):472-84
36. Olivecrona G, Beisiegel U. Lipid binding of apolipoprotein CII is required for stimulation of lipoprotein lipase activity against apolipoprotein CII-deficient chylomicrons. Arterioscler Thromb Vasc Biol. 1997 Aug; 17(8):1545-9.
37. Niot I, Poirier H, Tran TT, Besnard P. Intestinal absorption of long-chain fatty acids: evidence and uncertainties. Prog Lipid Res. 2009 Mar; 48(2):101-15.
38. Wong AT, Chan DC, Pang J, Watts GF, Barrett PH. Plasma apolipoprotein B-48 transport in obese men: a new tracer kinetic study in the postprandial state. J Clin Endocrinol Metab. 2014 Jan; 99(1): E122-6. doi: 10.1210/jc.2013-2477
39. Larsen MA, Goll R, Lekahl S, Moen OS, Florholmen J. Delayed clearance of triglyceride-rich lipoproteins in young, healthy obese subjects. Clin Obes. 2015 Oct 15
40. Petit V, Arnould L, Martin P, Monnot MC, Pineau T, Besnard P, et al. Chronic high-fat diet affects intestinal fat absorption and postprandial triglyceride levels in the mouse. J Lipid Res. 2007 Feb; 48(2):278-87.
41. Lin MC, Arbeeny C, Bergquist K, Kienzle B, Gordon DA, Wetterau JR. Cloning and regulation of hamster microsomal triglyceride transfer protein. The regulation is independent from that of other hepatic and intestinal proteins which participate in the transport of fatty acids and triglycerides. J Biol Chem. 1994; 269(46):29138-45.
42. Kondo H, Minegishi Y, Komine Y, Mori T, Matsumoto I, Abe K, et al. Differential regulation of intestinal lipid metabolism-related genes in obesity-resistant A/J vs. obesity-prone C57BL/6J mice. Am J Physiol Endocrinol Metab. 2006 Nov; 291(5):E1092-9.
43. Nassir F, Wilson B, Han X, Gross RW, Abumrad NA. CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine. J Biol Chem. 2007 Jul 6; 282(27):19493-501.
44. Douglass JD, Malik N, Chon SH, Wells K, Zhou YX, Choi AS, et al. Intestinal mucosal triacylglycerol accumulation secondary to decreased lipid secretion in obese and high fat fed mice. Front Physiol. 2012; 3:25. doi: 10.3389/fphys.2012.00025
45. Hayashi AA, Webb J, Choi J, Baker C, Lino M, Trigatti B, et al. Intestinal SR-BI is upregulated in insulinresistant states and is associated with overproduction of intestinal apoB48-containing lipoproteins. Am J Physiol Gastrointest Liver Physiol. 2011 Aug; 301(2):G326-37. doi: 10.1152/ajpgi.00425.2010
46. Drover VA, Nguyen DV, Bastie CC, Darlington YF, Abumrad NA, Pessin JE, et al. CD36 Mediates Both Cellular Uptake of Very Long Chain Fatty Acids and Their Intestinal Absorption in Mice. J Biol Chem. 2008 May 9; 283(19):13108-15. doi: 10.1074/jbc.M708086200
47. Kuda O, Pietka TA, Demianova Z, Kudova E, Cvacka J, Kopecky J, et al. Sulfo-N-succinimidyl oleate (SSO) inhibits fatty acid uptake and signaling for intracellular calcium via binding CD36 lysine 164: SSO also inhibits oxidized low density lipoprotein uptake by macrophages. J Biol Chem. 2013 May 31; 288(22):15547-55. doi: 10.1074/jbc.M113.473298
48. Liang CP, Han S, Okamoto H, Carnemolla R, Tabas I, Accili D, et al. Increased CD36 protein as a response to defective insulin signaling in macrophages. J Clin Invest. 2004 Mar; 113(5):764-73.
49. Pavlic M, Xiao C, Szeto L, Patterson BW, Lewis GF. Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids. Diabetes. 2010 Mar; 59(3):580-7. doi: 10.2337/db09-1297
50. Couture P, Tremblay AJ, Kelly I, Lemelin V, Droit A, Lamarche B. Key intestinal genes involved in lipoprotein metabolism are downregulated in dyslipidemic men with insulin resistance. J Lipid Res. 2014 Jan; 55(1):128-37. doi: 10.1194/jlr.M040071
51. Maljaars PW, Peters HP, Mela DJ, Masclee AA. Ileal brake: a sensible food target for appetite control. A review. Physiol Behav. 2008 Oct 20; 95(3):271-81. doi: 10.1016/j.physbeh.2008.07.018
52. Love-Gregory L, Sherva R, Sun L, Wasson J, Schappe T, Doria A, et al. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet. 2008 Jun 1; 17(11):1695-704. doi: 10.1093/hmg/ddn060